Excellence in clinical research from A to Z

Scroll down ⇩

About us

AtoZ-CRO GmbH is a full-service clinical research organisation (CRO) located in Overath near Cologne, Germany, with over 30 years of experience in clinical development and clinical study management. As a specialist for Germany, Europe, the US, and India, AtoZ-CRO offers a broad range of professional services and partner solutions for international clinical studies with pharmaceuticals and medical devices.


From its head office located in Overath, Germany, AtoZ-CRO manages and coordinates clinical studies of phase 0 through phase IV for national and international clients. The company forms a team of 35 highly experienced and dedicated industry professionals and medical specialists ensuring high standards in clinical study management. AtoZ-CRO is affiliated with a leading initiator of phase I studies in Warsaw, Poland.


Based on the company’s long-established international experience in clinical trial management and cooperation with high-rated business partners, AtoZ-CRO is proud to offer a broad range of services covering all clinical research needs, in particular for small and mid-sized pharmaceutical, biotech, and medical device companies.

Clinical Studies 

Contact us

Clinical Studies

Clinical Studies Phases 0 – IV

  • Planning of clinical studies
  • Preparation of study protocols
  • Design and implementation of CRFs (case report forms) and eCRFs
  • Processing of applications for ethical votes and permissions (e.g. CTA, IND)
  • Regulatory affairs issues
  • Legal EU representative

Other services

  • Monitoring
  • Post-marketing studies

-  NIS

-  PASS

-  Epidemiology

  • Pharmacovigilance
  • Biometry
  • Medical Writing and Translations

About us

Contact us

Contact us

AtoZ-CRO GmbH

Hauptstr. 77
51491 Overath
Tel: 02206 95 99 0
Fax: 02206 820 63
Email: info@atoz-cro.de
www.atoz-cro.de

Business Development

Dr. med. Karl-Peter Klein | Managing Director
Email: kp.klein@atoz-cro.de

Back to top ⇧

Go to article: Home | The Surgical Robot RevolutionGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: In This IssueGo to article: Telemed Company InsightGo to article: TelemedGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The magic touch: bringing sensory feedback to brain-controlled prostheticsGo to article: Picosun Company Insight Go to article: PicosunGo to article: Medicoat Go to article: The high-tech hunt for new biomarkersGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: OmnitronGo to article: Making robotic surgery safe: why training is key to avoiding tragedy Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: XavitechGo to article: Virtual pain relief: could VR start a rehab revolution?Go to article: Industrial Indexing Systems Company Insight Go to article: Industrial Indexing SystemsGo to article: Low battery: finding alternative ways to power medical devicesGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article: NSFGo to article: Hidden figures: lifting the lid on medical device failure reportingGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Watlow Plasmatech Company Insight Go to article: WatlowGo to article: Making sustainable medical devices: five top tipsGo to article: ARPA Company InsightGo to article: ARPAGo to article: ICU techGo to article: Predicting cardiac risk: new approaches in AI and blood testingGo to article: Under the skin: the medical device industry and the dark webGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Q&A: LifeBank on the challenge of getting blood from A to B in Nigeria Go to article: Cap Biomaterials Company Insight Go to article: Cap BiomaterialsGo to article: Debate: Can Alexa be trusted with our health questions?Go to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Pleora TechnologiesGo to article: Maraca InternationalGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: Combinostics Company Insight Go to article: EventsGo to article: Euroquartz Company InsightGo to article: EuroquartzGo to article: Next issueGo to article: mdi ConsultantsGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Sab BroeckskesGo to article: Qmedics Company Insight Go to article: Qmedics